Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

被引：0
|
作者：
Jonas Wallström
Kjell Geterud
Kimia Kohestani
Stephan E. Maier
Marianne Månsson
Carl-Gustaf Pihl
Andreas Socratous
Rebecka Arnsrud Godtman
Mikael Hellström
Jonas Hugosson
机构：
[1] University of Gothenburg,Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy
[2] Region Västra Götaland,Department of Radiology
[3] Sahlgrenska University Hospital,Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy
[4] University of Gothenburg,Department of Urology
[5] Region Västra Götaland,Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy
[6] Sahlgrenska University Hospital,undefined
[7] University of Gothenburg,undefined
来源：
European Radiology | 2021年 / 31卷
关键词：
Multiparametric magnetic resonance imaging; Prostatic neoplasms; Early detection of cancer; Contrast media;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8692 / 8702
页数：10
相关论文
共 50 条
  • [31] MRI-Targeted Biopsy in Prostate Cancer Screening
    Mathew, Rebecca
    Di Santo, Pietro
    Hibbert, Benjamin
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (22): : 2109 - 2111
  • [32] Diagnostic Performance of bi- and multiparametric MRI for Prostate Diagnostics with PI-RADSv2
    Krome, Susanne
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2020, 192 (02):
  • [33] A valuable MRI examination method for prostate cancer screening
    Yang, Xuezhen
    Shan, Lianqiang
    Cao, Haiming
    Jiang, Xu
    Ma, Xueping
    MEDICINE, 2020, 99 (48)
  • [34] Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial
    Josefsson, Andreas
    Mansson, Marianne
    Kohestani, Kimia
    Spyratou, Vasiliki
    Wallstrom, Jonas
    Hellstrom, Mikael
    Lilja, Hans
    Vickers, Andrew
    Carlsson, Sigrid V.
    Godtman, Rebecka
    Hugosson, Jonas
    EUROPEAN UROLOGY, 2024, 86 (03) : 223 - 229
  • [35] Specificity of prostate cancer screening with PSA:: Finnish ERSPC trial
    Tammela, TL
    Auvinen, A
    Määttänen, L
    Stenman, UH
    Ala-Opas, M
    Ruutu, M
    Juusela, H
    Hakama, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 431 - 431
  • [36] PSA screening reduced mortality from prostate cancer
    Nature Reviews Clinical Oncology, 2012, 9 (5) : 249 - 249
  • [37] RESULTS FROM THE GOTHENBURG RANDOMISED PROSTATE CANCER SCREENING TRIAL
    Hugosson, J.
    Aus, G.
    Bergdahl, S.
    Carlsson, S.
    Khatami, A.
    Lodding, P.
    Stranne, J.
    Holmberg, E.
    Lilja, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 37 - 37
  • [38] MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
    Eklund, M.
    Jaderling, F.
    Discacciati, A.
    Bergman, M.
    Annerstedt, M.
    Aly, M.
    Glaessgen, A.
    Carlsson, S.
    Gronberg, H.
    Nordstrom, T.
    EUROPEAN UROLOGY, 2021, 79 : S1430 - S1430
  • [39] Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
    Willis, Sarah R.
    Ahmed, Hashim U.
    Moore, Caroline M.
    Donaldson, Ian
    Emberton, Mark
    Miners, Alec H.
    van der Meulen, Jan
    BMJ OPEN, 2014, 4 (06):
  • [40] Multiplex blood-test and Magnetic Resonance Imaging (MRI) for prostate cancer screening: Results from the 2nd screening round in the STHLM3-MRI trial
    Discacciati, A.
    Abbadi, A.
    Chandra, J.
    Annerstedt, M.
    Glaessgen, A.
    Carlsson, S.
    Jaderling, F.
    Gronberg, H.
    Eklund, M.
    Nordstrom, T.
    EUROPEAN UROLOGY, 2024, 85 : S1611 - S1611
12345